Abstract:Objective1)to investigate the expression of Aquaporin-1(AQP1) in the blood vessel endothelium of ectopic endometrium of endometriosis; 2)to investigate the effect of AQP1 in the angiogenesis and the underlying mechanism.DesignClinical sample was used to research the location of AQP1 on the endometrium and expression difference of AQP1 between the normal and ectopic endometrium. Cell model(Human Umbilical Vein Endothelial Cells, HUVECs) was used to research the effect of AQP1 on the angiogenesis and the mechanism underlying. Animal model was used to research the effect of technically up-or down-regulation of AQP1 on the angiogenesis in vivo.Materials and MethodsMaterials:Cell lines:normal Human Umbilical Vein Endothelial Cells(HUVECs)Animal model:male nude miceClinical sample:normal and ectopic endometriumMethods:Western-blotRotary confocal microscopyMTTTranswell assaywound-healing assayImmunofluorescenceTube formationElectron microscopyImmunohistochemical staining.Results(1)clinical sample: AQP1 was expressed only in the endothelium of small vessels, whereas other cells, CD31 as a endothelial cell specific marker was co-localized. The expression level of AQP1 in the endothelial cells of ectopic endometrium was much higher than the endothelium of normal endometrium. (2)cell experiments: Knocking down AQP1 in HUVECs using specific SiRNA-AQP1 lentivirus decreased the proliferation, migraion, invasion and tubule formation of HUVECs, and broken the organization of cell skeleton into looping around the nuclei of the cell. Over expression of AQP1 in HUVECS using the flag-AQP1 lentivirus increased the proliferation, migration, invasion and tubule formation of HUVECs, and the formation of transcytoplasmic F-actin stress fibers. (3)animal model: Down-regulation of AQP1 in the endothelial cells can slow down the development of graft implanted in the nude mice through decreasing the angiogenesis.ConclusionIncreased angiogenesis induced by Up-regulation of AQP1 in the endothelial cells of ectopic endometrium plays a crucial role in the development of endometriosis. Objective1)to investigate the expression of Aquaporin-1(AQP1) in the blood vessel endothelium of ectopic endometrium of endometriosis; 2)to investigate the effect of AQP1 in the angiogenesis and the underlying mechanism. 1)to investigate the expression of Aquaporin-1(AQP1) in the blood vessel endothelium of ectopic endometrium of endometriosis; 2)to investigate the effect of AQP1 in the angiogenesis and the underlying mechanism. DesignClinical sample was used to research the location of AQP1 on the endometrium and expression difference of AQP1 between the normal and ectopic endometrium. Cell model(Human Umbilical Vein Endothelial Cells, HUVECs) was used to research the effect of AQP1 on the angiogenesis and the mechanism underlying. Animal model was used to research the effect of technically up-or down-regulation of AQP1 on the angiogenesis in vivo. Clinical sample was used to research the location of AQP1 on the endometrium and expression difference of AQP1 between the normal and ectopic endometrium. Cell model(Human Umbilical Vein Endothelial Cells, HUVECs) was used to research the effect of AQP1 on the angiogenesis and the mechanism underlying. Animal model was used to research the effect of technically up-or down-regulation of AQP1 on the angiogenesis in vivo. Materials and MethodsMaterials:Cell lines:normal Human Umbilical Vein Endothelial Cells(HUVECs)Animal model:male nude miceClinical sample:normal and ectopic endometriumMethods:Western-blotRotary confocal microscopyMTTTranswell assaywound-healing assayImmunofluorescenceTube formationElectron microscopyImmunohistochemical staining. Materials:Cell lines:normal Human Umbilical Vein Endothelial Cells(HUVECs)Animal model:male nude miceClinical sample:normal and ectopic endometriumMethods:Western-blotRotary confocal microscopyMTTTranswell assaywound-healing assayImmunofluorescenceTube formationElectron microscopyImmunohistochemical staining. Results(1)clinical sample: AQP1 was expressed only in the endothelium of small vessels, whereas other cells, CD31 as a endothelial cell specific marker was co-localized. The expression level of AQP1 in the endothelial cells of ectopic endometrium was much higher than the endothelium of normal endometrium. (2)cell experiments: Knocking down AQP1 in HUVECs using specific SiRNA-AQP1 lentivirus decreased the proliferation, migraion, invasion and tubule formation of HUVECs, and broken the organization of cell skeleton into looping around the nuclei of the cell. Over expression of AQP1 in HUVECS using the flag-AQP1 lentivirus increased the proliferation, migration, invasion and tubule formation of HUVECs, and the formation of transcytoplasmic F-actin stress fibers. (3)animal model: Down-regulation of AQP1 in the endothelial cells can slow down the development of graft implanted in the nude mice through decreasing the angiogenesis. (1)clinical sample: AQP1 was expressed only in the endothelium of small vessels, whereas other cells, CD31 as a endothelial cell specific marker was co-localized. The expression level of AQP1 in the endothelial cells of ectopic endometrium was much higher than the endothelium of normal endometrium. (2)cell experiments: Knocking down AQP1 in HUVECs using specific SiRNA-AQP1 lentivirus decreased the proliferation, migraion, invasion and tubule formation of HUVECs, and broken the organization of cell skeleton into looping around the nuclei of the cell. Over expression of AQP1 in HUVECS using the flag-AQP1 lentivirus increased the proliferation, migration, invasion and tubule formation of HUVECs, and the formation of transcytoplasmic F-actin stress fibers. (3)animal model: Down-regulation of AQP1 in the endothelial cells can slow down the development of graft implanted in the nude mice through decreasing the angiogenesis. ConclusionIncreased angiogenesis induced by Up-regulation of AQP1 in the endothelial cells of ectopic endometrium plays a crucial role in the development of endometriosis. Increased angiogenesis induced by Up-regulation of AQP1 in the endothelial cells of ectopic endometrium plays a crucial role in the development of endometriosis.

Identification of Estrogen Response Element in Aquaporin-3 Gene that Mediates Estrogen-induced Cell Migration and Invasion in Estrogen Receptor-positive Breast Cancer

Aquaporin 5 Plays a Role in Estrogen-Induced Ectopic Implantation of Endometrial Stromal Cells in Endometriosis

Identification of Estrogen Response Element in the Aquaporin-2 Gene That Mediates Estrogen-Induced Cell Migration and Invasion in Human Endometrial Carcinoma.

Aquaporin-1 plays a crucial role in estrogen-induced tubulogenesis of vascular endothelial cells.

Estrogen Nuclear Receptors Affect Cell Migration by Altering Sublocalization of AQP2 in Glioma Cell Lines

Reduced Migration of Ishikawa Cells Associated with Downregulation of Aquaporin-5.

Aquaporins and Endometriosis

AQP5 Gene Silencing Inhibits Proliferation and Migration of Ectopic Endometrial Glandular Epithelial Cells in Endometriosis

AQP2 is Regulated by Estradiol in Human Endometrium and is Associated with Spheroid Attachment Invitro

Aquaporin 3 and Skin

Aquaporin-3 mediates ovarian steroid hormone-induced motility of endometrial epithelial cells

Epigenomics-based Identification of Oestrogen-Regulated Long Noncoding RNAs in ER+ Breast Cancer.

Aquaporin-3 in Cancer

AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/β-catenin pathway in triple-negative breast cancer

AQP1-dependent Angiogenesis Plays a Crucial Role in the Pathogenesis of Endometriosis

AQP3-Dependent PI3K/Akt Modulation in Breast Cancer Cells

Modulatory effect of aquaporin 5 on estrogen-induced epithelial-mesenchymal transition in prostate epithelial cells

Inhibitory effect of AQP1 silencing on adhesion and angiogenesis in ectopic endometrial cells of mice with endometriosis through activating the Wnt signaling pathway

Down-regulated Aquaporin 5 Inhibits Proliferation and Migration of Human Epithelial Ovarian Cancer 3AO Cells

Role of Aquaporin 1 Signalling in Cancer Development and Progression

Aquaporins As Diagnostic and Therapeutic Targets in Cancer: How Far We Are?